Your browser doesn't support javascript.
loading
Randomised, phase 1, dose-finding study of MEDI4166, a PCSK9 antibody and GLP-1 analogue fusion molecule, in overweight or obese patients with type 2 diabetes mellitus.
Jain, Meena; Carlson, Glenn; Cook, William; Morrow, Linda; Petrone, Marcella; White, Nicholas E; Wang, Tao; Naylor, Jacqueline; Ambery, Philip; Lee, Charles; Hirshberg, Boaz.
Afiliación
  • Jain M; MedImmune Ltd, Milstein Building, Granta Park, Cambridge, CB21 6GH, UK. JainM@MedImmune.com.
  • Carlson G; AstraZeneca, Gaithersburg, MD, USA.
  • Cook W; MedImmune, Gaithersburg, MD, USA.
  • Morrow L; ProSciento Inc., Chula Vista, CA, USA.
  • Petrone M; MedImmune Ltd, Milstein Building, Granta Park, Cambridge, CB21 6GH, UK.
  • White NE; MedImmune Ltd, Milstein Building, Granta Park, Cambridge, CB21 6GH, UK.
  • Wang T; MedImmune, Gaithersburg, MD, USA.
  • Naylor J; MedImmune Ltd, Milstein Building, Granta Park, Cambridge, CB21 6GH, UK.
  • Ambery P; MedImmune Ltd, Milstein Building, Granta Park, Cambridge, CB21 6GH, UK.
  • Lee C; MedImmune, Gaithersburg, MD, USA.
  • Hirshberg B; MedImmune, Gaithersburg, MD, USA.
Diabetologia ; 62(3): 373-386, 2019 03.
Article en En | MEDLINE | ID: mdl-30593607

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Sobrepeso / Proproteína Convertasa 9 / Hipoglucemiantes / Anticuerpos / Obesidad Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Diabetologia Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Sobrepeso / Proproteína Convertasa 9 / Hipoglucemiantes / Anticuerpos / Obesidad Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Diabetologia Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido